Lymphangioleiomyomatosis: Calling It What It Is: A Low-Grade, Destructive, Metastasizing Neoplasm
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Lymphangioleiomyomatosis (LAM) is a progressive cystic lung disease primarily affecting women that has historically been classified and clinically managed as a nonneoplastic interstitial lung disease.The purpose of this document is to outline the accumulating data that support reclassification of LAM as a low-grade, destructive, metastasizing neoplasm.This major conceptual shift actually began more than 10 years ago in the pathology community.The 1999 World Health Organization classification of lung tumors regarded LAM as a "tumour-like" lesion, and in the 2004 classification, it was codified as a mesenchymal neoplasm (1, 2).The pulmonary community seems to have been slower to adopt this viewpoint, however, and continues to consider LAM one of the "other" idiopathic interstitial pneumonias.LAM occurs in patients with tuberous sclerosis complex (TSC) and also as a sporadic illness in patients without heritable disease.In either case, the smooth muscle-like "LAM cells" that diffusely infiltrate the lungs, lymphatics, and angiomyolipomas of patients with LAM have a low proliferative index and little or no evidence of cellular atypia, suggestive of a benign process.However, mounting genetic and cellular evidence has shown that, despite their innocent appearance, LAM cells exhibit the features and behaviors of a neoplasm.The finding of loss of heterozygosity for tuberous sclerosis complex genes in the lung, kidney, and lymphatic lesions of patients with LAM is consistent with clonal origins for these tumors.In the handful of patients who have had multiple tissues available for sequencing, identical TSC mutations found in the angiomyolipomas, lymph nodes, and lungs are indicative of seeding from a common, most likely extrapulmonary source (3).Angiomyolipomas have been proposed as a potential primary tumor, but they are present in a minority of patients with sporadic LAM (4).The expression of smooth muscle markers (5) and steroid hormone (estrogen and progesterone) receptors ( 6), variation of symptoms with the menstrual cycle (7), and report of LAM lesions in 9 of 10 resected uterine specimens from patients with LAM in a small series (8) are potentially consistent with a uterine primary tumor, at least in some patients.The TSC mutations that occur in LAM result in inappropriate, constitutive signaling through the
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy and safety of sirolimus in lymphangioleiomyomatosis
McCormack, F. X., Inoue, Y., Moss, J., Singer, L. G., Strange, C., Nakata, K., Barker, A. F., Chapman, J. T., Brantly, M. L., Stocks, J. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100391 · Cited by 1,099
Self-citationSun, Q., Chen, X., Ma, J., Peng, H., Wang, F., Zha, X., Wang, Y., Jing, Y., Yang, H., Chen, R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014769108 · Cited by 586
Cited by
The 2015 World Health Organization Classification of Lung Tumors
Travis, W. D., Brambilla, E., Nicholson, A. G., Yatabe, Y., Austin, J. H. M., Beasley, M. B., Chirieac, L. R., Dacic, S., Duhig, E., Flieder, D. B., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000630 · Cited by 4,520
Self-citationKhawar, M. U., Yazdani, D., Zhu, Z., Jandarov, R., Dilling, D. F., & Gupta, N. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.06.015 · Cited by 45
Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis
Ussavarungsi, K., Hu, X., Scott, J. P., Erasmus, D. B., Mallea, J. M., Alvarez, F., Lee, A. S., Keller, C. A., Ryu, J. H., & Burger, C. D. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.08.014 · Cited by 26
Olatoke, T., Wagner, A., Astrinidis, A., Zhang, E. Y., Guo, M., Zhang, A. G., Mattam, U., Kopras, E. J., Gupta, N., Smith, E. P., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf8549 · Cited by 13
Self-citation
Metadata
- Authors
- McCormack, F. X., Travis, W. D., Colby, T. V., Henske, E. P., & Moss, J.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-12-15
- Volume
- 186
- Issue
- 12
- Pages
- 1210-1212
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W1969798989
- Cited by
- 200
- References
- 2
- FWCI
- 8.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lymphangioleiomyomatosis: Calling It What It Is: A Low-Grade, Destructive, Metastasizing Neoplasm. https://app.cochat.ai/papers/10.1164/rccm.201205-0848oe
- The paper
- McCormack, F. X., Travis, W. D., Colby, T. V., Henske, E. P., & Moss, J. (2012). Lymphangioleiomyomatosis: Calling It What It Is: A Low-Grade, Destructive, Metastasizing Neoplasm. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201205-0848oe
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.